Company Overview of BioAdvance
BioAdvance is venture capital firm specializing in pre seed, seed, and start up investments. The firm seeks to invest in life sciences, therapeutic agents, diagnostics, health information technology, medical devices, research tools, and platform technologies focused on human health. It prefers to invest in Mid-Atlantic companies mainly based in the Southeastern region of Pennsylvania in the United States. The firm makes a maximum of $0.5 million equity investment. BioAdvance was founded in 2002 and is based in Philadelphia, Pennsylvania with an additional office in Radnor, Pennsylvania.
3711 Market Street
Philadelphia, PA 19104
Founded in 2002
Key Executives for BioAdvance
BioAdvance Key Developments
Similar Private Companies By Industry
|@Visory LLC||United States|
|1 Road Partners LLC||United States|
|11T Partners, LLC||United States|
|123Jump.com, Inc.||United States|
|1509225 Ontario, Inc.||United States|
Recent Private Companies Transactions
July 31, 2017
June 30, 2017
June 30, 2017
|Genome Profiling, LLC|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact BioAdvance, please visit www.bioadvance.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.